NZOWA opts for five-year think
The long-standing New Zealand Optical Wholesalers Association (NZOWA) has told members it intends to ‘rest’ for five years, to allow them to consider its longer-term future.
Staff reporters2 min read
Ophthalmology News
Colourful future for achromatopsia?
Preliminary results from two studies of gene therapies for achromatopsia have shown them to be safe while improving some patients’ photosensitivity and two-colour dark light-adapted perimetry.
Staff reporters1 min read
Extra O2 improves CXL efficacy
A laboratory study measuring oxygen kinetics during corneal crosslinking (CXL) of porcine eyes showed that supplementary oxygen had the potential to substantially increase the procedure’s efficacy.
Staff reporters2 min read
Improved gland transplantation technique for severe DED
A modified technique for minor salivary gland transplantation (MSGT) as a treatment for severe dry eye disease (DED) led to long-term improvements in visual acuity, ocular surface environment and
Staff reporters2 min read
DED drug misses endpoint
Ocular Therapeutix said a phase-2 study of its OTX-CSI insert for the treatment of dry-eye disease (DED) missed its primary endpoint of increased tear production. The US-based clinical trial was
Staff reporters1 min read
AI pupil scan detects glaucoma
Researchers at the Royal Melbourne Institute of Technology (RMIT) have demonstrated that an automated 10-second pupillary complexity test could detect open-angle glaucoma. Led by Professor Dinesh
Staff reporters2 min read
Ciclosporin gains public funding in Australia
Ciclosporin (Ikervis) has been listed on the Pharmaceutical Benefits Scheme (PBS) in Australia, saving around 7,500 severe keratitis patients with dry eye disease (DED) an estimated A$900 each per year, said Greg Hunt, Minister for Health and Aged Care.
Staff reporters2 min read
Uveitis increases Covid risks
A retrospective cohort study in the US has shown that patients with non-infectious uveitis (NIU) are more likely to contract Covid-19 and experience severe outcomes. However, this association was due to the demographics, comorbidities and medications of patients with NIU, rather than to NIU alone, r
Staff reporters1 min read
Anti-cataract implant study underway
An anti-cataract intravitreal implant has completed non-clinical testing, with an Australian phase 1/2 clinical study now underway.
Staff reporters1 min read
RANZCO commits to gender diversity
The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) has launched ‘The Tick’, an endorsement that an event has achieved 35% female representation.
Staff reporters1 min read
Studies back UWF-SS OCT
Two recent, independent studies have shown that Optos’ Silverstone retinal scanning system can improve patient management and alter treatment decisions. The first study¹ by researchers from the
Staff reporters2 min read
CAIRS trephine now in NZ
Medix21 has secured the exclusive New Zealand distribution rights for the CAIRS (corneal allogeneic intrastromal ring segments) double-bladed trephine for keratoconus.
Staff reporters2 min read